Global Epigenetics Market 2017-2021


◆タイトル:Global Epigenetics Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。


TechNavioが出版した当調査レポートでは、エピジェネティクスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、エピジェネティクスの世界市場規模及び予測、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社はエピジェネティクスの世界市場が2017-2021年期間中に年平均13.22%成長すると予測しています。当レポート上に記載されている主な企業は• Abcam• Bio-Rad Laboratories• Merck• Thermo Fisher Scientific等です。



About Epigenetics
Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.

Technavio’s analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global epigenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of epigenetics products.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abcam
• Bio-Rad Laboratories
• Merck
• Thermo Fisher Scientific

[Other prominent vendors]
• Active Motif
• BellBrook Labs
• BioVision
• Diagenode
• Epizyme
• Illumina
• New England Biolabs
• Novartis

[Market driver]
• Increasing prevalence of cancer
• For a full, detailed list, view our report

[Market challenge]
• Difficulty in finding predictive epigenetic biomarker
• For a full, detailed list, view our report

[Market trend]
• Increasing demand for personalized medicine
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline

PART 05: Market landscape
Market size and forecast
Five forces analysis

PART 06: Market segmentation by product
Global epigenetics market by product
Global epigenetics market by reagents
Global epigenetics market by kits
Global epigenetics market by others

PART 07: Geographical segmentation
Global epigenetics market by geography
Epigenetics market in Americas
Epigenetics market in EMEA
Epigenetics market in APAC

PART 08: Decision framework

PART 09: Drivers and challenges
Market drivers
Market challenges

PART 10: Market trends
Increasing use of epigenetics as a tool to understand development and disease
Increasing demand for personalized medicine
Rise in investment in R&D

PART 11: Vendor landscape
Competitive scenario
Investment opportunity analysis

PART 12: Key vendor analysis
Bio-Rad Laboratories
Thermo Fisher Scientific
Other prominent vendors

PART 13: Appendix
List of abbreviations

[List of Exhibits]
Exhibit 01: Epigenetic changes in DNA
Exhibit 02: Normal cellular functions regulated by epigenetic mechanisms and molecular abnormalities caused by epigenetic errors
Exhibit 03: Global epigenetics market: Market overview
Exhibit 04: Global epigenetics market 2016-2021 ($ billions)
Exhibit 05: Factors impacting global epigenetics market
Exhibit 06: Five forces analysis
Exhibit 07: Global epigenetics market by product 2016-2021 (% share)
Exhibit 08: Global epigenetics market by product: Snapshot
Exhibit 09: Global epigenetics market by reagents 2016-2021 ($ billions)
Exhibit 10: Global epigenetic market by kits 2016-2021 ($ billions)
Exhibit 11: Global epigenetic market by others 2016-2021 ($ billions)
Exhibit 12: Global epigenetics market by geography 2016-2021 (% share)
Exhibit 13: Global epigenetics market by geography: Snapshot
Exhibit 14: Epigenetics market in Americas 2016-2021 ($ billions)
Exhibit 15: Epigenetics market in EMEA 2016-2021 ($ billions)
Exhibit 16: Epigenetics market in APAC 2016-2021 ($ billions)
Exhibit 17: Competitive parameters in global epigenetics market
Exhibit 18: Investment opportunity mapping
Exhibit 19: Strategic success factors for companies
Exhibit 20: Abcam: Company profile
Exhibit 21: Abcam: Strength analysis
Exhibit 22: Abcam: Strategy assessment
Exhibit 23: Abcam: Opportunity assessment
Exhibit 24: Bio-Rad Laboratories: Company profile
Exhibit 25: Bio-Rad Laboratories: Strength analysis
Exhibit 26: Bio-Rad Laboratories: Strategy assessment
Exhibit 27: Bio-Rad Laboratories: Opportunity assessment
Exhibit 28: Merck: Company profile
Exhibit 29: Merck: Strength analysis
Exhibit 30: Merck: Strategy assessment
Exhibit 31: Merck: Opportunity assessment
Exhibit 32: Thermo Fisher Scientific: Company profile
Exhibit 33: Thermo Fisher Scientific: Strength analysis
Exhibit 34: Thermo Fisher Scientific: Strategy assessment
Exhibit 35: Thermo Fisher Scientific: Opportunity assessment


Abcam, Bio-Rad Laboratories, Merck, Thermo Fisher Scientific, Active Motif, BellBrook Labs, BioVision, CELGENE,, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.